Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Samsung
Elon Musk
Apple
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / Technology News / One in seven volunteers for Sputnik V report side effects
Technology

One in seven volunteers for Sputnik V report side effects

One in seven volunteers for Sputnik V report side effects
Written by Shubham Sharma
Sep 18, 2020, 09:01 pm 3 min read
One in seven volunteers for Sputnik V report side effects

Sputnik V, the COVID-19 vaccine developed and approved by Russia, has shown side effects in some trial volunteers. The reactions, according to state-run news agency TASS, have been reported in about one in seven people who have been inoculated by the shot as part of a massive Phase-3 study. Here is all you need to know about it.

Study report
14% subjects displayed reactions

In a recent conversation with TASS, Russian Health Minister Mikhail Murashko provided an update on the progress of the late-stage trial of Sputnik V. He said that the vaccine doses have been given to more than 300 of the planned 40,000 volunteers and about 14% of them have reported mild problems like weakness, muscle pain, and an increase in body temperature.

Serious effect
No serious effects seen so far

The minister emphasized that none of the volunteers have reported any serious side effects so far. Even for the 14% who witnessed the mild symptoms, the reactions last for 24 hours and level off by the next day. "The complications are described in the instructions (of the vaccine trial) and are predictable," he added while speaking to TASS.

Regimen
Sputnik V involves a two-dose regimen

Notably, the Sputnik V vaccine is given in two doses at a gap of 21 days. Each dose uses a different adenovirus and the spike protein from the coronavirus to induce an antibody-based immune response against COVID-19. Last month, Russian President Vladimir Putin claimed that the shot forms a 'stable immunity,' and one of his daughters has already been inoculated.

Approval
Approval with pending trials, raised questions

Even though the late-stage human trials of Sputnik V were not completed, Russia granted approval to the shot earlier last month, clearing it for public use. The move drew major flak from the scientific community, with many experts claiming that premature approval, and the lack of full safety and efficacy data, could put people at risk.

Distribution
Still, Russia has been moving ahead with production, distribution

Despite the alarms, Russia has been moving ahead with the production and distribution of the vaccine (for those at high-risk) while carrying out the late-stage trials at the same time. The country started mass-manufacturing last month and has already released the first batch of the shot in civil circulation, following necessary quality tests in the laboratories of Roszdravnadzor [Russia's medical device regulator].

Information
Mass-vaccination drives likely to begin in October or November

Further, Russia is expected to begin mass-inoculation drives for Sputnik V in October or November, which is when the initial data from the Phase-3 trial is likely to be revealed.

Deal
100 million doses to be supplied to India

The Russian Direct Investment Fund, the sovereign wealth fund that backed the Sputnik V project, has inked a deal with Hyderabad-based Dr. Reddy's Laboratories to conduct a clinical trial of the vaccine on the Indian population and supply 100 million doses. However, the progress of the trial and the supply of the doses would depend on approvals from India's Central Drugs Standard Control Organization.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Shubham Sharma
Shubham Sharma
Twitter
Editor with over five years of experience in covering all things science, consumer tech, space tech, AI, infosec, and business. A commerce graduate from University of Lucknow. I have been handling Tech beat at NewsBytes since 2018.
Latest
Russia News
Vaccine
Vladimir Putin
Central Drugs Standard Control Organization (CDSCO)
COVID-19
Related
Latest
Ahead of global debut, new-generation Mercedes-Benz GLC SUV teased
Ahead of global debut, new-generation Mercedes-Benz GLC SUV teased Auto
'Thor: Love and Thunder': 5 things to expect
'Thor: Love and Thunder': 5 things to expect Entertainment
Moto G71s debuts with Snapdragon 695 SoC: Details here
Moto G71s debuts with Snapdragon 695 SoC: Details here Technology
IPL 2022: LSG qualify for playoffs after beating KKR
IPL 2022: LSG qualify for playoffs after beating KKR Sports
Professor demands gun license from PM after Gyanvapi 'shivling' comments
Professor demands gun license from PM after Gyanvapi 'shivling' comments India
Russia News
Coup to overthrow Putin underway: Ukraine amid 'ill health' reports
Coup to overthrow Putin underway: Ukraine amid 'ill health' reports World
Putin 'seriously ill,' claims ex-spy; oligarch says it's blood cancer
Putin 'seriously ill,' claims ex-spy; oligarch says it's blood cancer World
Putin to undergo cancer treatment, transfer power to Patrushev: Reports
Putin to undergo cancer treatment, transfer power to Patrushev: Reports World
18 dead after 500-kg bombs hit residential buildings in Ukraine
18 dead after 500-kg bombs hit residential buildings in Ukraine World
"NATO gave green light to bombing Ukraine": President Zelensky
"NATO gave green light to bombing Ukraine": President Zelensky World
More News
Vaccine
COVID-19: India logs 2,487 fresh cases, 13 more fatalities
COVID-19: India logs 2,487 fresh cases, 13 more fatalities India
COVID-19: India logs 2,858 fresh cases, 11 more fatalities
COVID-19: India logs 2,858 fresh cases, 11 more fatalities India
India: Phase-2 trials of world's first one-shot pneumococcal vaccine soon
India: Phase-2 trials of world's first one-shot pneumococcal vaccine soon India
India inching closer to launching its first dengue vaccine
India inching closer to launching its first dengue vaccine India
National Vaccination Day 2022: Know theme, history, significance
National Vaccination Day 2022: Know theme, history, significance Lifestyle
More News
Vladimir Putin
Russian President Vladimir Putin undergoes new surgery
Russian President Vladimir Putin undergoes new surgery World
Russia defending 'motherland' in Ukraine, says Putin on Victory Day
Russia defending 'motherland' in Ukraine, says Putin on Victory Day World
Sarmat: Russia tests new nuclear-capable missile, Vladimir Putin warns enemies
Sarmat: Russia tests new nuclear-capable missile, Vladimir Putin warns enemies World
Russia-Ukraine war: 'Battle for Donbas' has begun, says President Zelenskyy
Russia-Ukraine war: 'Battle for Donbas' has begun, says President Zelenskyy World
Russia-Ukraine war: 'Missile strikes on Kyiv will increase,' says Russia
Russia-Ukraine war: 'Missile strikes on Kyiv will increase,' says Russia World
More News
Central Drugs Standard Control Organization (CDSCO)
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine India
J&J withdraws vaccine approval request in India, CDSCO says
J&J withdraws vaccine approval request in India, CDSCO says India
Expert panel says no to Covovax's children trials in India
Expert panel says no to Covovax's children trials in India India
COVAXIN phase 2/3 trials for 2-18-year-olds recommended by expert panel
COVAXIN phase 2/3 trials for 2-18-year-olds recommended by expert panel India
Foreign COVID-19 vaccines: Decision on EUA applications within three days
Foreign COVID-19 vaccines: Decision on EUA applications within three days India
More News
COVID-19
COVID-19: India reports 1,829 new cases, 33 more fatalities
COVID-19: India reports 1,829 new cases, 33 more fatalities India
COVID-19: India reports 1,569 new cases, 19 more deaths
COVID-19: India reports 1,569 new cases, 19 more deaths India
COVID-19: India logs 2,202 new cases; 27 more deaths
COVID-19: India logs 2,202 new cases; 27 more deaths India
North Korea: 8,20,620 fresh COVID-19 cases in just 3 days
North Korea: 8,20,620 fresh COVID-19 cases in just 3 days World
North Korea reports 6 COVID-19 deaths, isolates 1,87,800 people
North Korea reports 6 COVID-19 deaths, isolates 1,87,800 people World
More News
Related
Government expert panel recommends conducting trials on mixing Covishield, COVAXIN
Government expert panel recommends conducting trials on mixing Covishield, COVAXIN India
COVID-19: Delhi to vaccinate all above 45 within 4 weeks
COVID-19: Delhi to vaccinate all above 45 within 4 weeks India
Next News Article
Next News Article

Love Technology news?

Subscribe to stay updated.

Science Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022